Amgen, Inc. ( NASDAQ: AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - ...

Johnny Depp as Captain Jack Sparrow? Robert Downey Jr. in "Tropic Thunder"? You'd be shocked by the roles that have received ...

OpenAI was cofounded by Musk and Altman in 2018 as a non-profit, with Musk leaving before the company took off. Musk’s ...

Tesla (TSLA) is advancing 3% after investment bank Benchmark started coverage of the automaker with a Buy rating.

Oppenheimer analyst Owen Lau maintained a Buy rating on S&P Global (SPGI – Research Report) today and set a price target of $610.00. The ...

In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...

Analysts at Oppenheimer said in a research note on Tuesday that billionaire Elon Musk's recent bid for ChatGPT parent OpenAI ...

Bleakley Financial Group LLC lowered its position in PulteGroup, Inc. (NYSE:PHM – Free Report) by 5.3% during the fourth ...

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “market perform” rating restated by analysts at Oppenheimer in a research note issued to investors on Monday, MarketBeat.com reports ...

BYD had previously offered self-driving technology to cars costing $30,000 and higher, but analysts noted that will now be offered on 21 models, including some under $10,000. Tesla's full self-driving ...

The biggest companies, those that operate in more than one state, have as much as $6 billion in debt maturing next year, ...

Tesla shares fell 7% on Tuesday and have dropped for five straight days, wiping out over $200 billion in market cap.